LLY

885.74

+0.89%↑

JNJ

242.36

+0.87%↑

ABBV

213.05

+1.61%↑

NVS

150.35

+1.42%↑

MRK

117.86

-1.52%↓

LLY

885.74

+0.89%↑

JNJ

242.36

+0.87%↑

ABBV

213.05

+1.61%↑

NVS

150.35

+1.42%↑

MRK

117.86

-1.52%↓

LLY

885.74

+0.89%↑

JNJ

242.36

+0.87%↑

ABBV

213.05

+1.61%↑

NVS

150.35

+1.42%↑

MRK

117.86

-1.52%↓

LLY

885.74

+0.89%↑

JNJ

242.36

+0.87%↑

ABBV

213.05

+1.61%↑

NVS

150.35

+1.42%↑

MRK

117.86

-1.52%↓

LLY

885.74

+0.89%↑

JNJ

242.36

+0.87%↑

ABBV

213.05

+1.61%↑

NVS

150.35

+1.42%↑

MRK

117.86

-1.52%↓

Search

Stevanato Group SpA

Fechado

SetorSaúde

13.42 0.22

Visão Geral

Variação de preço das ações

24h

Atual

Mín

13.31

Máximo

13.85

Indicadores-chave

By Trading Economics

Rendimento

-2M

47M

Vendas

40M

343M

P/E

Médio do Setor

25.085

57.05

Margem de lucro

13.738

Funcionários

6,010

EBITDA

18M

90M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+82.43% upside

Dividendos

By Dow Jones

Próximos Ganhos

7 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-79M

4B

Abertura anterior

13.2

Fecho anterior

13.42

Sentimento de Notícias

By Acuity

50%

50%

153 / 349 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

Stevanato Group SpA Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

30 de mar. de 2026, 23:15 UTC

Notícias Principais

U.K. Shoppers Paid a Little More This Month But Worse May yet Lie Ahead

30 de mar. de 2026, 22:36 UTC

Notícias Principais

Australian Government Rules Out Boots on the Ground in the Middle East

30 de mar. de 2026, 22:13 UTC

Aquisições, Fusões, Aquisições de Empresas

Sun Life Financial Agrees to Buy Bell Partners for $350 Million

30 de mar. de 2026, 21:00 UTC

Ganhos

Aktis Oncology Gets FDA Clearance for Phase 1 Billion Trial of Tumor Treatment

30 de mar. de 2026, 20:15 UTC

Notícias Principais

Fed's Williams: Middle-East Developments Have Added Significant Economic Uncertainty

30 de mar. de 2026, 23:40 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

30 de mar. de 2026, 23:40 UTC

Conversa de Mercado

Nikkei May Decline on Higher Energy Cost Concerns -- Market Talk

30 de mar. de 2026, 23:36 UTC

Conversa de Mercado

Gold Edges Lower Amid Divergent Signals on U.S.-Iran Talks -- Market Talk

30 de mar. de 2026, 23:12 UTC

Conversa de Mercado

Alcoa Earnings Outlook Boosted by Market Disruptions -- Market Talk

30 de mar. de 2026, 22:49 UTC

Conversa de Mercado

Fed's Williams: Core Inflation Forecast Is Little Changed -- Market Talk

30 de mar. de 2026, 22:44 UTC

Conversa de Mercado

Fed's Williams: Risks to Both Sides of Dual Mandate Higher -- Market Talk

30 de mar. de 2026, 22:43 UTC

Conversa de Mercado

Fed's Williams Says Focus Is on Inflation Expectations Being Well Anchored -- Market Talk

30 de mar. de 2026, 22:42 UTC

Conversa de Mercado

South32 Should Go for Growth, Says New Bull -- Market Talk

30 de mar. de 2026, 22:18 UTC

Conversa de Mercado

Paragon Care's Chances of Using Levy to Pass on Higher Costs `Close to Zero' -- Market Talk

30 de mar. de 2026, 22:05 UTC

Conversa de Mercado

Northern Star's New Bull Argues Case for Asset Sales -- Market Talk

30 de mar. de 2026, 21:58 UTC

Aquisições, Fusões, Aquisições de Empresas

Sun Life Financial Agrees to Buy Bell Partners for $350M

30 de mar. de 2026, 21:39 UTC

Aquisições, Fusões, Aquisições de Empresas

Sun Life Sees 1Q Charge to Net of C$236M From BGO, Crescent Deals

30 de mar. de 2026, 21:38 UTC

Aquisições, Fusões, Aquisições de Empresas

Sun Life: Completes Remaining Equity Interest Purchases of BGO, Crescent Capital

30 de mar. de 2026, 21:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Sun Life to Buy Fully Bell Partners for $350M >SLF.T

30 de mar. de 2026, 21:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Unilever Shareholders Expected to Own Two-Thirds of New Food Entity, Sources Say -- WSJ

30 de mar. de 2026, 21:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Unilever Nears Deal to Create $60 Billion Food Giant With McCormick -- WSJ

30 de mar. de 2026, 21:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Deal Could Be Announced As Soon As Tuesday, Sources Say -- WSJ

30 de mar. de 2026, 21:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Unilever Nears Cash-and-Stock Deal to Combine Food Business With McCormick, Sources Say -- WSJ

30 de mar. de 2026, 21:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Deal Set to Value Combined Food Business At Around $60B Including Debt, Sources Say -- WSJ

30 de mar. de 2026, 21:25 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

30 de mar. de 2026, 21:25 UTC

Conversa de Mercado

Warehouse Showing Cost Discipline But Margin Goal at Risk -- Market Talk

30 de mar. de 2026, 21:03 UTC

Aquisições, Fusões, Aquisições de Empresas

Sun Life: Completes Equity Interest Purchases of BGO and Crescent Cap, Announces Acquisition of Bell Partners, a Multifamily Real Estate Investment Manager

30 de mar. de 2026, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

30 de mar. de 2026, 20:09 UTC

Ganhos

This Stock Looks Like a Solid AI Bet -- and Wall Street Hasn't Noticed Yet -- Barrons.com

30 de mar. de 2026, 20:00 UTC

Notícias Principais

Fed's Williams: Middle-East Conflict 'Will Likely Boost Overall Inflation in Coming Months'

Comparação entre Pares

Variação de preço

Stevanato Group SpA Previsão

Preço-alvo

By TipRanks

82.43% parte superior

Previsão para 12 meses

Média 24.5 USD  82.43%

Máximo 32 USD

Mínimo 17.5 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Stevanato Group SpA - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

6 ratings

4

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

21.56 / 22.61Suporte e Resistência

Curto Prazo

Weak Bullish Evidence

Médio Prazo

Weak Bearish Evidence

Longo Prazo

Bullish Evidence

Sentimento

By Acuity

153 / 349 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
help-icon Live chat